Company Overview of InnoPharma, LLC
InnoPharma, LLC develops niche generic and specialty pharmaceutical/bio-pharmaceutical products. The company develops sterile injectable and ophthalmic pharmaceutical products. It also works with manufacturing and clinical research organizations worldwide for commercialization of its developed products. InnoPharma, LLC was founded in 2005 and is based in Piscataway, New Jersey.
10 Knightsbridge Road
Piscataway, NJ 08854
Founded in 2005
Key Executives for InnoPharma, LLC
Co-Founder and Chief Operating Officer
Vice President of Business Development & Alliance Management
Vice President of Project Management
Compensation as of Fiscal Year 2014.
InnoPharma, LLC Key Developments
Sandoz Canada to Make, Use, Sell, Market and Distribute InnoPharma's Olanzapine Injection in Canada
Jul 30 14
InnoPharma Inc. announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa(R) injection), in Canada. Olanzapine is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania. As the developer of this generic injectable drug, InnoPharma has entered into an agreement with Sandoz Canada Inc., pursuant to which Sandoz Canada will make, use, sell, market and distribute Olanzapine Injection in Canada.
InnoPharma, LLC Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:00 AM
Dec 9 13
InnoPharma, LLC Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 08:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Navneet Puri, Founder, Chief Executive Officer, President and Director.
InnoPharma Inc. Completes $20 Million Term Loan Facility
Nov 13 13
InnoPharma, Inc. announced that it has closed on a $20 million term loan facility, provided by Athyrium Capital Management through its Athyrium Opportunities Fund. Proceeds will support the company's ongoing development of complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms. Armentum Partners acted as financial advisors to InnoPharma for this transaction.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 16, 2014